500 breast cancer patients help scientists crack the code of treatment resistance

This study is for 500 adults with non-metastatic breast cancer who are about to start treatment like chemotherapy or targeted therapy before surgery. Researchers will collect tumor tissue, blood, and sometimes stool samples and MRI scans during treatment. The goal is to learn why some cancers respond well and others don't, and to find better ways to predict which patients might have their cancer return.